Teng, E., Manser, P. T., Bohorquez, S. S., Wildsmith, K. R., Pickthorn, K., Baker, S. L., . . . Weimer, R. M. (2021). Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease. BMC.
Cita Chicago Style (17a ed.)Teng, Edmond, Paul T. Manser, Sandra Sanabria Bohorquez, Kristin R. Wildsmith, Karen Pickthorn, Suzanne L. Baker, Michael Ward, Geoffrey A. Kerchner, y Robby M. Weimer. Baseline [18F]GTP1 Tau PET Imaging Is Associated with Subsequent Cognitive Decline in Alzheimer’s Disease. BMC, 2021.
Cita MLA (8a ed.)Teng, Edmond, et al. Baseline [18F]GTP1 Tau PET Imaging Is Associated with Subsequent Cognitive Decline in Alzheimer’s Disease. BMC, 2021.
Precaución: Estas citas no son 100% exactas.